Clinic
Primary Care Medical Services of Poinciana INC
Primary Care Medical Services of Poinciana INC was paid $3.69M by Medicaid between Jan 2018 and Dec 2024, across 138 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoPRIMARY CARE MEDICAL SERVICES OF POINCIANA INC
KISSIMMEE, FL 34744
KISSIMMEE, FL 34744
33aNPI1376093609assigned 10/11/2016
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$3.69M
24GClaims729,166
24DCodes billed138
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Florida
Rank by total paid#18 of 293
Median peer was paid$114K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,351 | $72K | |
| 2019 | 76,138 | $379K | |
| 2020 | 99,294 | $460K | |
| 2021 | 131,703 | $604K | |
| 2022 | 288,939 | $939K | |
| 2023 | 87,649 | $753K | |
| 2024incomplete | 41,092 | $482K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 25,852 | 17,969 | $886K |
| H1000 | Prenatal care, at-risk assessment | 22% | 13,426 | 8,165 | $811K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.1% | 7,596 | 5,432 | $337K |
| D0330 | Panoramic radiographic image | 3.8% | 3,918 | 3,840 | $140K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.6% | 5,960 | 3,896 | $133K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 2.7% | 2,142 | 1,641 | $99K |
| D1110 | Prophylaxis - adult | 2.5% | 3,333 | 3,249 | $94K |
| 81003 | 2.3% | 21,021 | 13,558 | $86K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.3% | 1,464 | 1,015 | $85K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 2.0% | 5,507 | 5,284 | $75K |
| D1120 | Dental cleaning, childProphylaxis - child | 2.0% | 3,002 | 2,866 | $72K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 1.9% | 2,488 | 1,785 | $70K |
126 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 924 | $61K |
| 99203 | Doctor's office visit, new patient (routine) | 1.5% | 1,259 | $54K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.4% | 1,286 | $53K |
| D1351 | Sealant - per tooth | 1.4% | 7,546 | $51K |
| D0150 | Comprehensive oral evaluation - new or established patient | 1.4% | 3,921 | $51K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.3% | 858 | $49K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 914 | $48K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 5,455 | $32K |
| D0272 | Bitewings - two radiographic images | <1% | 6,153 | $25K |
| 92551 | <1% | 7,947 | $24K | |
| D1206 | Topical application of fluoride varnish | <1% | 7,035 | $22K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 385 | $22K |
| 85018 | <1% | 10,982 | $21K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 334 | $21K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 10,194 | $20K |
| 99383 | <1% | 245 | $15K | |
| D0274 | Bitewings - four radiographic images | <1% | 1,506 | $15K |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 8,765 | $15K |
| D0140 | Limited oral evaluation - problem focused | <1% | 1,519 | $14K |
| 81025 | <1% | 3,469 | $13K | |
| D0603 | <1% | 933 | $12K | |
| 99381 | <1% | 142 | $12K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 171 | $12K |
| 99384 | <1% | 176 | $11K | |
| D1330 | <1% | 5,636 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 449 | $9K |
| 1111F | <1% | 51,995 | $9K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 148 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,710 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 694 | $7K |
| 99385 | <1% | 77 | $7K | |
| 99443 | <1% | 422 | $6K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 143 | $6K |
| D1310 | <1% | 5,273 | $6K | |
| D1999 | <1% | 73 | $4K | |
| 90461 | <1% | 1,261 | $4K | |
| 99442 | <1% | 456 | $4K | |
| 3078F | <1% | 35,326 | $4K | |
| 3725F | <1% | 35,076 | $4K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 124 | $3K |
| 3074F | <1% | 37,956 | $3K | |
| 59430 | <1% | 33 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 543 | $2K |
| 99382 | <1% | 47 | $2K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 55 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 15 | $2K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 29 | $2K |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 12,967 | $1K |
| 1126F | <1% | 37,737 | $1K | |
| 1000F | <1% | 36,986 | $1K | |
| 1036F | <1% | 35,133 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,975 | $1K |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 22,900 | $929.94 |
| 99441 | <1% | 202 | $925.98 | |
| 96160 | <1% | 31,471 | $695.15 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 123 | $679.69 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 29 | $590.20 |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 26 | $562.84 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 78 | $516.60 |
| 82274 | <1% | 157 | $510.28 | |
| H0049 | Alcohol and/or drug screening | <1% | 18,880 | $498.79 |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 155 | $458.25 |
| 1160F | <1% | 44,100 | $412.18 | |
| 3079F | <1% | 5,498 | $394.11 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 30,697 | $370.19 |
| D0999 | Unspecified diagnostic procedure, by report | <1% | 14 | $280.00 |
| 1159F | <1% | 44,353 | $276.70 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 58 | $273.21 |
| 96127 | <1% | 20,932 | $261.00 | |
| 90651 | <1% | 460 | $216.18 | |
| 0521F | <1% | 728 | $200.26 | |
| 1158F | <1% | 1,882 | $191.26 | |
| 1125F | <1% | 2,436 | $184.41 | |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 85 | $180.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,257 | $177.37 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 62 | $158.50 |
| 3075F | <1% | 1,430 | $113.97 | |
| 0502F | <1% | 1,411 | $109.94 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,123 | $97.90 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $86.67 |
| 3080F | <1% | 151 | $86.47 | |
| 3077F | <1% | 699 | $76.52 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 19 | $72.25 |
| 99459 | <1% | 13 | $62.29 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 82 | $58.22 |
| 1034F | <1% | 652 | $25.68 | |
| 4000F | <1% | 267 | $25.22 | |
| 36416 | <1% | 1,722 | $15.00 | |
| 1170F | <1% | 78 | $12.61 | |
| 3048F | <1% | 658 | $12.61 | |
| 90686 | <1% | 1,515 | $10.01 | |
| 99173 | <1% | 4,566 | $8.54 | |
| 90633 | 0% | 256 | $0.00 | |
| 90670 | 0% | 449 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 162 | $0.00 |
| 90672 | 0% | 103 | $0.00 | |
| 99177 | 0% | 1,868 | $0.00 | |
| 3050F | 0% | 27 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 85 | $0.00 |
| 90715 | 0% | 17 | $0.00 | |
| 90734 | 0% | 39 | $0.00 | |
| 1124F | 0% | 146 | $0.00 | |
| 1039F | 0% | 50 | $0.00 | |
| 99499 | 0% | 14 | $0.00 | |
| 90710 | 0% | 31 | $0.00 | |
| 87081 | 0% | 18 | $0.00 | |
| 3008F | 0% | 1,872 | $0.00 | |
| 3044F | 0% | 1,041 | $0.00 | |
| 3049F | 0% | 246 | $0.00 | |
| 4015F | 0% | 58 | $0.00 | |
| 1157F | 0% | 202 | $0.00 | |
| 96161 | 0% | 571 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 82 | $0.00 |
| 76499 | 0% | 253 | $0.00 | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | 0% | 32 | $0.00 |
| 94760 | 0% | 162 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 59 | $0.00 |
| T1029 | Comprehensive environmental lead investigation, not including laboratory analysis, per dwelling | 0% | 14 | $0.00 |
| 87430 | 0% | 13 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 15 | $0.00 |
| 88142 | 0% | 14 | $0.00 | |
| 90620 | 0% | 31 | $0.00 | |
| 0501F | 0% | 14 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 13 | $0.00 |
| 3061F | 0% | 13 | $0.00 | |
| 90697 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON-CORNETT, BELINDA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Primary Care Medical Services of Poinciana INC | Kissimmee, FL | $179K |
| Primary Care Medical Services of Poinciana INC | Kissimmee, FL | $87K |
| Primary Care Medical Services of Poinciana INC | Saint Cloud, FL | $86K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.